As part of its commitment to science and innovation in the service of well-being, Epixlife is participating in a new research project led by
Dr. María Pérez and the Valentia Huesca Foundation, aimed at exploring integrative approaches for individuals diagnosed with autism spectrum disorder (ASD).
This study is part of an academic initiative in collaboration with a specialized foundation and seeks to contribute to a deeper understanding of behavior and well-being in this population. Epixlife’s S-Drive technology is included in the assessment protocol designed by the research team, with the goal of expanding the tools available for a comprehensive analysis of the individual.
Dr. Pérez, recognized for her clinical approach that integrates conventional medicine and complementary therapies, leads a project that values diverse perspectives within the field of health, always focusing on improving the quality of life of individuals.
That said, and in line with the ethical standards that govern all scientific research, it is important to emphasize that this study is still in the development phase, and the results are pending review and publication. Therefore, specific details regarding the methodology, sample, or preliminary findings will not be disclosed, in accordance with the confidentiality protocols established by the academic teams involved.
At Epixlife, we appreciate the trust placed in our technology and reaffirm our commitment to rigorous, ethical, and transformative research as a means of continuing to generate a positive impact in people’s lives.
